Inventors with similar research interests:
Location History:
- Vosselaat, BE (1976)
- Turnhout, BE (1976 - 1977)
- Beerse, 2340, BE (2002)
- Beerse, BE (2002)
- Beerse B-2340, BE (2002)
- 2340 Beerse, BE (2007)
- Vosselaar, BE (1976 - 2020)
Company Filing History:
102 out of 2,076 
4 out of 111 
3 out of 32 
Years Active: 1976-2020
Title: Jan Heeres: A Prolific Inventor in HIV Prevention and Replication Inhibition
Introduction:
Jan Heeres, hailing from Vosselaar, Belgium, is a distinguished individual with a remarkable track record in the field of pharmaceutical research and development. With an impressive record of 124 patents to his name, Heeres has made significant contributions in the prevention and replication inhibition of HIV. In this article, we delve into Heeres' latest patents, career highlights, notable collaborations, and conclude with his profound impact on the field of medicine.
Latest Patents:
Among Jan Heeres' latest patents, two inventions stand out for their potential to combat HIV. His invention titled "Prevention of HIV Infection" explores the use of a parenteral formulation comprising the NNRTI TMC278 for the long-term prevention of HIV infection. The intermittent administration of this formulation at extended time intervals has shown promising results in reducing the risk of HIV transmission.
Another groundbreaking invention by Heeres is the "HIV Replication Inhibiting Pyrimidines." This invention focuses on a class of N-oxides and their derivatives, which act as effective HIV replication inhibitors. The patent covers the chemical structures, pharmaceutical compositions, and methods of using these inhibitors as medicines in the treatment of HIV.
Career Highlights:
Jan Heeres has had an illustrious career, primarily working with renowned pharmaceutical companies. One such notable affiliation was with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson. Janssen Pharmaceutica NV is known for its pioneering contributions in the development of innovative pharmaceuticals.
Collaborations:
Throughout his career, Jan Heeres has had the opportunity to collaborate with exceptional individuals, further enriching his contributions to the field. Notably, he worked alongside esteemed colleagues such as Paul Adriaan Jan Janssen and Lucien Maria Henricus Koymans. Their combined expertise and efforts have undoubtedly accelerated advancements in HIV prevention and treatment.
Conclusion:
Jan Heeres' extensive portfolio of patents exemplifies his unwavering commitment to tackling the challenges posed by HIV. His innovations in the prevention of HIV infection and replication inhibition have paved the way for new treatment strategies and improved patient outcomes. With his collaborations and contributions to esteemed companies like Janssen Pharmaceutica NV, Heeres has established himself as a key figure in the field of pharmaceutical research. As the world continues to face the HIV epidemic, Jan Heeres' work serves as a beacon of hope, driving progress in the fight against this devastating disease.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.